文献速递糖尿病

1型糖尿病成人患者的糖尿病设备使用:使用障碍与潜在干预目标

Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets.
PubMed 文献 · Diabetes Care · 2016-11-29

该研究调查了1503名成人1型糖尿病交换项目参与者,探讨设备使用障碍、设备使用者与非使用者的特征差异及年龄和性别差异。结果显示最常见的可改变障碍是佩戴设备的麻烦(47%)和不喜欢身上有设备(35%),CGM使用者较非使用者年龄更大、病程更长、技术态度更积极且障碍更少,18-25岁年龄组设备使用率最低、糖尿病痛苦最高且HbA1c最高。作者认为增加设备使用的努力需针对佩戴设备的身体障碍,并将年轻成人作为未来干预的重点。

要点

  • 最常见的可改变障碍是佩戴设备的麻烦(47%)和不喜欢身上有设备(35%)。
  • CGM使用者较非使用者年龄更大、病程更长、技术态度更积极且障碍更少。
  • 18-25岁组CGM和胰岛素泵使用率最低、糖尿病痛苦最高、HbA1c最高。

核心结论

  • 增加设备使用的努力需针对佩戴设备的身体障碍。
  • 年轻成人设备使用率最低、痛苦最高且HbA1c最高,应成为未来增加设备使用干预的重点。

研究设计与样本

  • 调查了1503名成人1型糖尿病交换项目参与者,平均年龄35.3(SD 14.8)岁,平均诊断病程20.4(SD 12.5)年。
  • 使用糖尿病痛苦量表、技术使用态度(一般和糖尿病特异性)以及设备使用障碍和停用设备原因量表。

主要发现

  • 最常见的可改变障碍与佩戴设备的麻烦(47%)和不喜欢身上有设备(35%)有关。
  • CGM使用者(37%)较非使用者年龄更大(平均38.3 vs 33.5岁),糖尿病病程更长(22.9 vs 18.8年),技术态度更积极(22.6-26.0 vs 21.4-24.8),报告的设备使用障碍更少(3.3 vs 4.3)。
  • 最年轻年龄组(18-25岁)的CGM使用率最低(26% vs 40-48%),胰岛素泵使用率最低(64% vs 69-77%),糖尿病痛苦最高(2.2 vs 1.8-2.1),HbA1c水平最高(8.3% [67 mmol/mol] vs 7.2-7.4% [55-57 mmol/mol])。

临床怎么用

  • 作者认为增加设备使用的努力需针对佩戴设备的身体障碍。
  • 作者认为应将年轻成人作为未来增加设备使用干预的重点。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diabetes devices (insulin pumps, continuous glucose monitors [CGMs]) are associated with benefits for glycemic control, yet uptake of these devices continues to be low. Some barriers to device uptake may be modifiable through psychosocial intervention, but little is known about which barriers and which patients to target. RESEARCH DESIGN AND METHODS: We surveyed 1,503 adult T1D Exchange participants (mean age 35.3 [SD 14.8] years, mean diagnosis duration 20.4 [SD 12.5] years) to investigate barriers to device uptake, understand profiles of device users versus nonusers, and explore differences by age and sex. Scales used were the Diabetes Distress Scale, Technology Use Attitudes (General and Diabetes-Specific), and Barriers to Device Use and Reasons for Discontinuing Devices. RESULTS: Most commonly endorsed modifiable barriers were related to the hassle of wearing devices (47%) and disliking devices on one's body (35%). CGM users (37%) were older than nonusers (mean 38.3 vs. 33.5 years), had diabetes for longer (22.9 vs. 18.8 years), had more positive technology attitudes (22.6-26.0 vs. 21.4-24.8), and reported fewer barriers to using diabetes technology than nonusers (3.3 vs. 4.3). The youngest age-group (18-25 years) had the lowest CGM (26% vs. 40-48%) and insulin pump (64% vs. 69-77%) uptake, highest diabetes distress (2.2 vs. 1.8-2.1), and highest HbA1c levels (8.3% [67 mmol/mol] vs. 7.2-7.4% [55-57 mmol/mol]). CONCLUSIONS: Efforts to increase device use need to target physical barriers to wearing devices. Because young adults had the lowest device uptake rates, highest distress, and highest HbA1c compared with older age-groups, they should be the focus of future interventions to increase device use.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Tanenbaum ML, Hanes SJ, Miller KM, et al. Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets. Diabetes Care. 2016. PMID: 27899489. doi:10.2337/dc16-1536

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。